Searched for
AD5 NCOV
Booster dose of Covishield offers best immune response: Lancet studyFor both binding and functional antibodies, in participants primed with Covishield, homologous boosting with Covishield offers better immun...- T cells provide immunity against severe Covid: Study'Cellular immune response' refers to immunity through T lymphocytes or T cells that recognise specific foreign antigens and kill cells carr...
- Covishield 63% effective overall, 81% against severe illness: StudyDespite Delta’s ability to reduce humoral/antibody-led immune response, the cell-mediated immunity - immunity driven by T cells at sites of...
- China rolls out first one-jab COVID-19 vaccine: ReportChina's first Ad5-nCoV COVID-19 vaccine was rolled out on Friday, the state-run Global Times reported on Sunday. It is the only single-dose...
- Pakistan to purchase 1.2 million COVID-19 vaccine doses from China's SinopharmChina approved a COVID-19 vaccine developed by an affiliate of state-backed pharmaceutical giant Sinopharm on Thursday, its first approved ...
- Pakistan approves initial funds to purchase COVID-19 vaccineThe initial phase of vaccinations would focus on providing free shots for frontline health workers and people above the age of 65 years, Fa...
- Covid-19 vaccine front-runner held back by China’s spat with CanadaChinese customs hasn’t approved shipments of CanSino’s vaccine to Canada, the National Research Council of Canada said in a Aug. 26 email. ...
- Serum Institute initiates phase 2, 3 clinical study for potential COVID-19 vaccineAccording to the Clinical Trial Registry India, the scientific title of the study says that phase 2/3 clinical trial will be observer-blind...
- Testing of China’s candidate vaccine begins in RussiaThe Ad5-nCoV vaccine already has approval for use by China’s military after early and mid-stage trials, and further late-stage trials are b...
- China's CanSino in talks for COVID-19 vaccine Phase III trial overseasChina's success in driving down COVID-19 infections has made it harder to conduct large-scale vaccine trials, and so far only a few countri...
- How a Chinese firm jumped to the front of the virus vaccine raceIn May, CanSino became the first globally to publish a full scientific study on its early human trials, an important step because it allows...
- First COVID-19 vaccine human trial finds it is safe, induces immune responseIn the trial, carried out in 108 healthy adults, the vaccine demonstrated promising results after 28 days, with the final results to be eva...
- Microbiologist is first in line for Oxford University's Covid-19 vaccine trialElisa Granato is the first volunteer in an initial group of 800 to be part of the ground-breaking trial, which is hoped will be the answer ...
- Oxford Covid-19 vaccine trial on 510 humans from todayA total of 510 healthy volunteers, aged 18 to 55, will take part in the trial. While some participants will receive the vaccine – called Ch...
- Six Indian companies working on COVID-19 vaccine, many challenges in finding a preventive: ExpertsNearly 70 'vaccine candidates' are being tested and at least three have moved to the human clinical trial stage, but a vaccine for the nove...
- As Asia panics, one country wins praise for approach to coronavirusSingapore Prime Minister Lee Hsien Loong said “fear can do more harm than the virus itself” amid reports of long lines and hoarding at loca...
- Coronavirus death toll jumps past 500 in China, more cases found on cruise ship off JapanHubei province, the epicentre of the epidemic, reported 70 new deaths on Wednesday and 2,987 new confirmed cases - more than 80% of the tot...
- Death toll in China's coronavirus climbs sharply to 80 with 2,744 confirmed casesChina continued to reel under deadly coronavirus epidemic on Monday with the death toll due to it sharply rising to 80 amid the country's N...
Load More
